Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Zaficefta

Xellia forms scientific advisory board

Will further progress on innovative anti-infectives

- PMLiVE

NICE backs Pfizer drug in kidney cancer

Inlyta near end of two-year struggle for recommendation

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

- PMLiVE

ASH: Pfizer eyes re-launch of Mylotarg

Data supports drug's use in acute myeloid leukaemia

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

- PMLiVE

Pfizer’s CMO joins board of Tenet

Freda Lewis-Hall to advise healthcare services firm

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

- PMLiVE

Pfizer signs $2.85bn immuno-oncology alliance

Will jointly develop Merck KGaA's lead anti-PD-L1 drug

- PMLiVE

Pfizer gets FDA nod for meningitis vaccine Trumenba

Ahead of Novartis’ rival drug Bexsero

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

FDA votes to keep severe warning on Pfizer’s Chantix

Will not relax anti-smoking drug's side effect warning

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links